---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-104291"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T12:54:02.698897+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Plus Therapeutics sets 2026 annual meeting for May 14; proxy deadlines March 22

## Summary
- Annual meeting scheduled for May 14, 2026 at 9:00 a.m. ET, held virtually.
- Record date for stockholders is March 18, 2026.
- Deadline for Rule 14a-8 stockholder proposals and director nominations: March 22, 2026.
- Meeting date is more than 30 days before 2025 anniversary, rendering prior proxy deadlines void.
- Universal proxy rule compliance notice also due by March 22, 2026.

## SEC filing metadata
- accession: 0001193125-26-104291
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- confidence: low
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312526104291/0001193125-26-104291-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312526104291/pstv-20260311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-104291
- JSON: https://secwatch.observer/filing/0001193125-26-104291.json
- Plain text: https://secwatch.observer/filing/0001193125-26-104291.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.